Search for: "Brian Dunlay and Matthew Navarre" Results 1 - 5 of 5
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2020, 8:02 am by Brian Dunlay and Matthew Navarre
By Brian Dunlay and Matthew Navarre On March 13, 2020, in response to the recent outbreak of the coronavirus disease (COVID-19), the Securities and Exchange Commission released guidance providing regulatory flexibility to reporting companies seeking to change the date, time, or location of annual shareholder meetings and use new technologies, such as “virtual” shareholder meetings, that avoid the need for in-person meetings. [read post]
17 Mar 2020, 8:02 am by Brian Dunlay and Matthew Navarre
By Brian Dunlay and Matthew Navarre On March 13, 2020, in response to the recent outbreak of the coronavirus disease (COVID-19), the Securities and Exchange Commission released guidance providing regulatory flexibility to reporting companies seeking to change the date, time, or location of annual shareholder meetings and use new technologies, such as “virtual” shareholder meetings, that avoid the need for in-person meetings. [read post]
10 Mar 2020, 11:44 am by Brian Dunlay and Matthew Navarre
By Brian Dunlay and Matthew Navarre On March 4, 2020, the Securities and Exchange Commission issued an Order granting conditional relief from certain filing obligations under the federal securities laws for reporting companies whose compliance may be delayed by the coronavirus disease (COVID-19). [read post]
10 Mar 2020, 11:44 am by Brian Dunlay and Matthew Navarre
By Brian Dunlay and Matthew Navarre On March 4, 2020, the Securities and Exchange Commission issued an Order granting conditional relief from certain filing obligations under the federal securities laws for reporting companies whose compliance may be delayed by the coronavirus disease (COVID-19). [read post]
10 Mar 2020, 11:44 am by Brian Dunlay and Matthew Navarre
By Brian Dunlay and Matthew Navarre On March 4, 2020, the Securities and Exchange Commission issued an Order granting conditional relief from certain filing obligations under the federal securities laws for reporting companies whose compliance may be delayed by the coronavirus disease (COVID-19). [read post]